Amy E. Schade
Impact in
-
- Cancer-related Molecular Pathways
-
- Epigenetics and DNA Methylation
- RNA modifications and cancer
- Ubiquitin and proteasome pathways
- Genomics and Chromatin Dynamics
- FOXO transcription factor regulation
- RNA Research and Splicing
Papers in
-
- Ubiquitin and proteasome pathways 3
- FOXO transcription factor regulation 2
- RNA modifications and cancer 2
- Epigenetics and DNA Methylation 2
- Histone Deacetylase Inhibitors Research 1
- Oncology 5
- Cancer-related Molecular Pathways 4
- Co-authors
- James A. DeCaprio (6 shared papers)Martin Fischer (3 shared papers)Timothy B. Branigan (2 shared papers)Gerd A. Müller (1 shared paper)Hilary E. Nicholson (1 shared paper)Matthew G. Oser (1 shared paper)Karen Cichowski (3 shared papers)David Kozono (1 shared paper)
- Journals
- Cancer Research (2 papers)PLoS Biology (1 paper)Cell Reports (1 paper)Journal of Clinical Investigation (1 paper)Trends in Biochemical Sciences (1 paper)
- Partner nations
- United StatesGermanyCanada
In The Last Decade
Amy E. Schade
9 papers receiving 334 citations
Peers
Comparison fields: 5 of 68
- Oncology 117
- Molecular Biology 249
- Cell Biology 56
- Cancer Research 44
- Aging 5
Countries citing papers authored by Amy E. Schade
This map shows the geographic impact of Amy E. Schade's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy E. Schade with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy E. Schade more than expected).
Fields of papers citing papers by Amy E. Schade
This network shows the impact of papers produced by Amy E. Schade. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy E. Schade. The network helps show where Amy E. Schade may publish in the future.
Co-authors
The 25 scholars most cited alongside Amy E. Schade, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 129 | |
| 2 | 2019 | 60 | |
| 3 | 2019 | 50 | |
| 4 | 2020 | 39 | |
| 5 | 2021 | 27 | |
| 6 | 2023 | 15 | |
| 7 | 2023 | 12 | |
| 8 | 2004 | 4 | |
| 9 | 2019 | 1 | |
| 10 | 2023 | 0 |
About Amy E. Schade
Amy E. Schade is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Small Animals and Public Health, Environmental and Occupational Health, having authored 10 papers that have together received 337 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (4 papers), Ubiquitin and proteasome pathways (3 papers), FOXO transcription factor regulation (2 papers), RNA modifications and cancer (2 papers), Epigenetics and DNA Methylation (2 papers), Hippo pathway signaling and YAP/TAZ (1 paper), Histone Deacetylase Inhibitors Research (1 paper) and Cancer Research and Treatments (1 paper). The work is most often cited by research in Oncology (117 citations), Molecular Biology (249 citations), Cell Biology (56 citations), Cancer Research (44 citations) and Aging (5 citations). Amy E. Schade has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include James A. DeCaprio, Martin Fischer, Timothy B. Branigan, Gerd A. Müller, Hilary E. Nicholson, Matthew G. Oser, Karen Cichowski, David Kozono, Larissa A. Sambel and Peter Deraska. Their work appears in journals such as Cancer Research, PLoS Biology, Cell Reports, Journal of Clinical Investigation and Trends in Biochemical Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.